Sun Pharma ups offer for Taro Pharma to $43 per share in cash
Mint Mumbai|December 13, 2023
Sun Pharmaceutical Industries on Tuesday said it has revised upwards the price at which it proposed to fully acquire Israel-based Taro Pharmaceutical Industries to $43 per share in cash.
Sun Pharma ups offer for Taro Pharma to $43 per share in cash

In May this year, the company announced a non-binding indication of interest to acquire all of the outstanding ordinary shares of Taro for a purchase price of $38 per ordinary share in cash through a reverse triangular merger.

هذه القصة مأخوذة من طبعة December 13, 2023 من Mint Mumbai.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة December 13, 2023 من Mint Mumbai.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من MINT MUMBAI مشاهدة الكل
Vaz, Mani and Gupta to head RIL-Disney JV
Mint Mumbai

Vaz, Mani and Gupta to head RIL-Disney JV

The ₹70,000-cr media giant is likely to transform entertainment in India

time-read
2 mins  |
November 15, 2024
Trump and Putin's rapport masks deeper tensions
Mint Mumbai

Trump and Putin's rapport masks deeper tensions

Warm words between two leaders doesn't necessarily signal a thaw in U.S.-Russia relations

time-read
5 mins  |
November 15, 2024
Mint Mumbai

CCPA orders investigation into Ola Electric

Many customers reported that issues persisted as complaints were closed prematurely without result

time-read
1 min  |
November 15, 2024
'Revised norms will benefit big auditors'
Mint Mumbai

'Revised norms will benefit big auditors'

Proposed revisions in the audit standard for consolidated financial statements of business groups could lead to the concentration of the audit market around big audit firms at the expense of other auditors, said an official of the Institute of Chartered Accountants of India (ICAI), the profession's self-regulator and rule maker.

time-read
2 mins  |
November 15, 2024
Mint Mumbai

Muted Q2 sparks a rethink at Mamaearth

Honasa Consumer Ltd, the listed beauty and personal care firm behind Mamaearth, plans to make significant adjustments to its product lineup, marketing approach, and investment allocation across categories to revive growth for its flagship brand, which underperformed in the September quarter.

time-read
1 min  |
November 15, 2024
'Design cities for next 100 years, think big'
Mint Mumbai

'Design cities for next 100 years, think big'

DLF's K.P. Singh calls for the overhaul of India's urban planning approach

time-read
2 mins  |
November 15, 2024
Companies scan diversity, inclusion before M&A deals
Mint Mumbai

Companies scan diversity, inclusion before M&A deals

The rising importance of D&I is closely tied to the growing focus on ESG assessments

time-read
3 mins  |
November 15, 2024
Sebi curbs to help boost BSE's Sensex options, says CEO
Mint Mumbai

Sebi curbs to help boost BSE's Sensex options, says CEO

BSE & NSE have been asked to offer one weekly options expiry as 9 in 10 individuals lose money in index options

time-read
1 min  |
November 15, 2024
Mint Mumbai

Tata Chemicals Europe rejig helps, but soda ash is a worry

Tata Chemicals Europe Ltd (TCEL), a subsidiary of Tata Chemicals Ltd, has embarked on a restructuring exercise.

time-read
1 min  |
November 15, 2024
Clarity on AGR to help raise bank debt, says Voda Idea CEO
Mint Mumbai

Clarity on AGR to help raise bank debt, says Voda Idea CEO

Clarity from the government on adjusted gross revenue (AGR) will move the needle on Vodafone Idea Ltd's efforts to raise debt from lenders, its top executive said, adding that promoters, along with the management, were in discussions with banks for raising ₹35,000 crore.

time-read
1 min  |
November 15, 2024